- Home
- ACCS vs ZYXI Comparison
ACCS vs ZYXI Comparison
Compare ACCS & ZYXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACCS
- ZYXI
- Stock Information
- Founded
- ACCS 1988
- ZYXI 1996
- Country
- ACCS United States
- ZYXI United States
- Employees
- ACCS N/A
- ZYXI N/A
- Industry
- ACCS Publishing
- ZYXI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- ACCS Consumer Discretionary
- ZYXI Health Care
- Exchange
- ACCS Nasdaq
- ZYXI Nasdaq
- Market Cap
- ACCS 42.6M
- ZYXI 44.8M
- IPO Year
- ACCS N/A
- ZYXI N/A
- Fundamental
- Price
- ACCS $9.43
- ZYXI $1.32
- Analyst Decision
- ACCS Strong Buy
- ZYXI Hold
- Analyst Count
- ACCS 1
- ZYXI 3
- Target Price
- ACCS $14.00
- ZYXI $3.00
- AVG Volume (30 Days)
- ACCS 7.8K
- ZYXI 74.3K
- Earning Date
- ACCS 11-11-2025
- ZYXI 10-30-2025
- Dividend Yield
- ACCS N/A
- ZYXI N/A
- EPS Growth
- ACCS N/A
- ZYXI N/A
- EPS
- ACCS N/A
- ZYXI N/A
- Revenue
- ACCS $22,562,000.00
- ZYXI $144,808,000.00
- Revenue This Year
- ACCS $0.03
- ZYXI N/A
- Revenue Next Year
- ACCS $11.45
- ZYXI $7.07
- P/E Ratio
- ACCS N/A
- ZYXI N/A
- Revenue Growth
- ACCS 26.44
- ZYXI N/A
- 52 Week Low
- ACCS $7.79
- ZYXI $1.23
- 52 Week High
- ACCS $13.35
- ZYXI $9.33
- Technical
- Relative Strength Index (RSI)
- ACCS 32.67
- ZYXI 39.67
- Support Level
- ACCS $9.40
- ZYXI $1.33
- Resistance Level
- ACCS $9.99
- ZYXI $1.43
- Average True Range (ATR)
- ACCS 0.40
- ZYXI 0.08
- MACD
- ACCS -0.03
- ZYXI 0.01
- Stochastic Oscillator
- ACCS 3.26
- ZYXI 9.35
About ACCS ACCESS Newswire Inc.
ACCESS Newswire Inc is a Public Relations (PR) and Investor Relations (IR) solutions provider. The group focuses on innovation, customer service, and value-driven offerings, ACCESS Newswire empowers brands.
About ZYXI Zynex Inc.
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company operates business as one operating segment which includes two revenue types: Devices and Supplies. Its markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.